Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200131046317N1Phase 3Completed
Phase 3, randomised, single-blind trial in West syndrome comparing High-dose prednisolone with ACTH followed by prednisolone (2 arms). Primary endpoints: Seizure status and Electroencephalography. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200131046317N1.